Stay updated on Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added revision: v3.4.3. Deleted revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T18:20:39.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the previous funding/operating status notice (Revision: v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T09:27:19.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new banner informs users that information may not be up to date due to a government funding lapse and that the NIH Clinical Center is open, with a revision tag updated to v3.4.1. The page also lists recent revision dates (2026-01-12, 2026-01-28, 2026-12).
    Difference
    0.7%
    Check dated 2026-02-04T05:55:46.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a Show glossary control and updated page metadata to include Last Update Submitted that Met QC Criteria and No FEAR Act Data. The site revision was updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T04:14:51.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:26:20.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Massachusetts as a site and updated the page revision to v3.3.3. The old 'Massachusetts Locations' label was removed and the HHS Vulnerability Disclosure link was deleted.
    Difference
    0.2%
    Check dated 2025-12-23T21:16:20.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in Oral Cavity Squamous Cell Clinical Trial page.